School of Medicine
Showing 11-20 of 70 Results
-
Robert Diep, MD
Clinical Assistant Professor, Medicine - Hematology
BioDr. Diep is a board-certified, fellowship-trained hematologist with Stanford’s Hematology Program and Hematologic Cancer Program. He is also a clinical assistant professor with the Department of Medicine, Division of Hematology.
He diagnoses and treats patients with a wide range of nonmalignant hematology conditions. His special interests include clotting disorders, bleeding disorders, hemoglobinopathies, and disorders affecting blood count. Subspecialty interests include anticoagulation and thrombosis.
Dr. Diep’s practice style emphasizes shared decision-making by building patient-physician relationships and using the best available evidence to create treatment plans. He is passionate about improving care for patients with blood disorders and has helped expand access to hematology care by launching an electronic consult service for primary care providers.
Dr. Diep’s research interests include anticoagulation, thrombosis, and bleeding disorders. He has participated in research projects that have received funding from the National Heart, Lung, and Blood Institute.
Dr. Diep has published in multiple peer-reviewed journals, and has presented to his peers at national and regional meetings.
He is a member of the American Society of Hematology, American Society of Clinical Oncology, Hemostasis and Thrombosis Research Society, International Society of Hemostasis and Thrombosis, and Anticoagulation Forum. Dr. Diep serves as quality director for the Division of Hematology. -
Tamara Dunn
Clinical Associate Professor, Medicine - Hematology
BioDr. Tamara Dunn is a clinical associate professor in the Division of Hematology at the Stanford University School of Medicine. She is a clinician with a special interest in medical education, diversity, equity, and inclusion. Specifically, she is committed to improving workforce diversity and creating inclusive workplaces. She is currently the Program Director for the Stanford Hematology/Oncology Fellowship and one of the Associate Chairs of Diversity and Inclusion for the Department of Medicine at Stanford. She is a member of the inaugural American Society of Hematology (ASH) Ambassador Cohort and serves on the ASH Women in Hematology committee, which she co-chairs. She is on the steering committee and is a mentor for Stanford’s Leadership Education in Advancing Diversity (LEAD) program. She takes pride in treating underserved veterans at the Palo Alto Veterans Hospital, where she sees both classical and malignant hematology. Outside of medicine she enjoys singing, dancing, sports (Go Chiefs! Go Warriors!), board games, movies, and spending time with friends and family including her 3 young children, spouse, and energetic vizsla Casey.
-
Bita Fakhri, MD, MPH
Assistant Professor of Medicine (Hematology)
BioDr. Bita Fakhri is Assistant Professor of Medicine in the Division of Hematology at Stanford University School of Medicine. She specializes in the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), hairy cell leukemia, and other hematologic malignancies. As a clinical scientist, Dr. Fakhri is dedicated to caring for patients, teaching trainees, and researching novel therapies for patients with CLL/SLL. Dr. Fakhri has co-authored numerous publications on topics including CLL, novel targeted agents, and cellular therapies for patients with hematologic malignancies. Currently, Dr. Fakhri is the director of the CLL clinical trial portfolio at Stanford, and serves on the National Comprehensive Cancer Network CLL panel.
-
Lawrence Tim Goodnough
Professor of Pathology and of Medicine (Hematology), Emeritus
Current Research and Scholarly InterestsImproving blood utilization
Promoting alternatives to blood transfusion
Quality improvements -
Jason Gotlib
Professor of Medicine (Hematology)
Current Research and Scholarly InterestsMy research interests include phase I/II clinical trial evaluation of novel therapies for the following diseases:
--Myelodysplastic syndromes (MDS)
--Chronic myelogenous leukemia (CML)
--Acute myelogenous leukemia (AML)
--Myeloproliferative disorders (MPDs) including:
Hypereosinophilic syndrome
Systemic mastocytosis
BCR-ABL-negative MPDs -
Peter Greenberg
Professor of Medicine (Hematology), Emeritus
Current Research and Scholarly InterestsDr Greenberg's clinical research involves design and coordination of clinical trials using experimental drugs with biologic focus for both lower and higher risk MDS patients not responding to standard therapies. These studies are particularly based on his prior laboratory investigations of gene expression and hematopoietic regulation in MDS patients. He is Coordinator of the International Working Group for Prognosis in MDS (IWG-PM) which generated the revised MDS classification system (the IPSS-R) and the mutation-based prognostic risk system, the IPSS-Molecular (IPSS-M). This project uses such findings to more specifically characterize and treat MDS patients. He is Chair of the NCCN Practice Guidelines Panel for MDS.
